Compare Cassava Sciences Inc (FLNA) vs Manhattan Associates Inc (MANH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Manhattan Associates Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Manhattan Associates Inc trades at $195 (market cap $11.38B). The key difference: Manhattan Associates Inc is far larger — about 238.3× Cassava Sciences Inc's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | MANH | |
|---|---|---|
Market Cap | $47.75M | $11.38B |
Sector | Health | Technology |
52-Week High | $4.64 | $220.19 |
52-Week Low | $0.87 | $120.88 |
Enterprise Value | -$34.93M | $11.25B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →
